Absence of Dickkopf (Dkk)-3 protein expression is correlated with longer disease-free survival and lower incidence of metastasis in head and neck squamous cell carcinoma

Oncology Letters

Volumn 3, Issue 2, 2012, Pages 273-280

  Katase, Naoki ^a   Lefeuvre, Mathieu ^a   Gunduz, Mehmet ^a,b   Gunduz, Esra ^b   Beder, Levent Bekir ^c   Grenman, Reidar ^d   Fujii, Masae ^a   Tamamura, Ryo ^a   Tsujigiwa, Hidetsugu ^a   Nagatsuka, Hitoshi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b FATIH UNIVERSITY   (Turkey)

^c WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^d TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Dkk 3; Head and neck squamous cell carcinoma; Immunohistochemistry

Indexed keywords

DICKKOPF 3 PROTEIN; GLYCOPROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER INCIDENCE; CANCER SURVIVAL; CARCINOGENESIS; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE FREE SURVIVAL; FEMALE; HEAD AND NECK CARCINOMA; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING;

EID: 84855218276     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2011.473     Document Type: Article

References (34)

1. Ha PK, Chang SS, Glazer CA, Califano JA and Sidransky D: Molecular techniques and genetic alterations in head and neck cancer. Oral Oncol 45: 335-339, 2009.
2. Gunduz M, Ouchida M, Fukushima K, Hanafusa H, Etani T, Nishioka S, Nishizaki K and Shimizu K: Genomic structure of the human ING1 gene and tumor-specific mutations detected in head and neck squamous cell carcinomas. Cancer Res 60: 3143-3146, 2000.
3. Gunduz M, Ouchida M, Fukushima K, Ito S, Jitsumori Y, Nakashima T, Nagai N, Nishizaki K and Shimizu K: Allelic loss and reduced expression of the ING3, a candidate tumor suppressor gene at 7q31, in human head and neck cancers. Oncogene 21: 4462-4470, 2002.
4. Gunduz M, Nagatsuka H, Demircan K, Gunduz E, Cengiz B, Ouchida M, Tsujigiwa H, Yamachika E, Fukushima K, Beder L, et al: Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas. Gene 356: 109-117, 2005.
5. Cengiz B, Gunduz E, Gunduz M, Beder LB, Tamamura R, Bagci C, Yamanaka N, Shimizu K and Nagatsuka H: Tumor specific mutation and downregulation of ING5 detected in oral squamous cell carcinoma. Int J Cancer 127: 2088-2094, 2010.
6. Borkosky SS, Gunduz M, Nagatsuka H, Beder LB, Gunduz E, Ali MA, Rodriguez AP, Cilek MZ, Tominaga S, Yamanaka N, Shimizu K and Nagai N: Frequent deletion of ING2 locus at 4q35.1 associates with advanced tumor stage in head and neck squamous cell carcinoma. J Cancer Res Clin Oncol 135: 703-713, 2009.
7. Katase N, Gunduz M, Beder L, Gunduz E, Lefeuvre M, Hatipoglu OF, Borkosky SS, Tamamura R, Tominaga S, Yamanaka N, et al: Deletion at Dickkopf (dkk)-3 locus (11p15.2) is related with lower lymph node metastasis and better prognosis in head and neck squamous cell carcinomas. Oncol Res 17: 273-282, 2008.
8. Katase N, Gunduz M, Beder LB, Gunduz E, Al Sheikh Ali M, Tamamura R, Yaykasli KO, Yamanaka N, Shimizu K and Nagatsuka H: Frequent allelic loss of Dkk-1 locus (10q11.2) is related with low distant metastasis and better prognosis in head and neck squamous cell carcinomas. Cancer Invest 28: 103-110, 2010.
9. Song J, Chang I, Chen Z, Kang M and Wang CY: Characterization of side population in HNSCC: highly invasive, chemoresistant and abnormal Wnt signaling. PLoS One 5: e11456, 2010.
10. Lee EJ, Jo M, Rho SB, Park K, Yoo YN, Park J, Chae M, Zhang W and Lee JH: Dkk3, downregulated in cervical cancer, functions as a negative regulator of beta-catenin. Int J Cancer 124: 287-297, 2009.
11. Mizobuchi Y, Matsuzaki K, Kuwayama K, Kitazato K, Mure H, Kageji T and Nagahiro S: REIC/Dkk-3 induces cell death in human malignant glioma. Neuro Oncol 10: 244-253, 2008.
12. Yang B, Du Z, Gao YT, Lou C, Zhang SG, Bai T, Wang YJ and Song WQ: Methylation of Dickkopf-3 as a prognostic factor in cirrhosis-related hepatocellular carcinoma. World J Gastroenterol 16: 755-763, 2010.
13. Veeck J, Wild PJ, Fuchs T, Schüffler PJ, Hartmann A, Knüchel R and Dahl E: Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer. BMC Cancer 9: 217, 2009.
14. Kuphal S, Lodermeyer S, Bataille F, Schuierer M, Hoang BH and Bosserhoff AK: Expression of Dickkopf genes is strongly reduced in malignant melanoma. Oncogene 25: 5027-5036, 2006.
15. Zenzmaier C, Untergasser G, Hermann M, Dirnhofer S, Sampson N and Berger P: Dysregulation of Dkk-3 expression in benign and malignant prostatic tissue. Prostate 68: 540-547, 2008.
16. Maehata T, Taniguchi H, Yamamoto H, Nosho K, Adachi Y, Miyamoto N, Miyamoto C, Akutsu N, Yamaoka S and Itoh F: Transcriptional silencing of Dickkopf gene family by CpG island hypermethylation in human gastrointestinal cancer. World J Gastroenterol 14: 2702-2714, 2008.
17. Zhang Y, Dong WG, Yang ZR, Lei XF and Luo HS: Expression of Dickkopf-3 in esophageal squamous cell carcinoma. Zhonghua Nei Ke Za Zhi 49: 325-327, 2010.
18. Yamachika E, Tsujigiwa H, Shirasu N, Ueno T, Sakata Y, Fukunaga J, Mizukawa N, Yamada M and Sugahara T: Immobilized recombinant human bone morphogenetic protein-2 enhances the phosphorylation of receptor-activated Smads. J Biomed Mater Res A 88: 599-607, 2009.
19. Kikuchi A, Kishida S and Yamamoto H: Regulation of Wnt signaling by protein-protein interaction and post-translational modifications. Exp Mol Med 38: 1-10, 2006.
20. Kurayoshi M, Oue N, Yamamoto H, Kishida M, Inoue A, Asahara T, Yasui W and Kikuchi A: Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion. Cancer Res 66: 10439-10448, 2006.
21. Sato H, Suzuki H, Toyota M, Nojima M, Maruyama R, Sasaki S, Takagi H, Sogabe Y, Sasaki Y, Idogawa M, et al: Frequent epigenetic inactivation of DICKKOPF family genes in human gastrointestinal tumors. Carcinogenesis 28: 2459-2466, 2007.
22. Suzuki H, Toyota M, Carraway H, Gabrielson E, Ohmura T, Fujikane T, Nishikawa N, Sogabe Y, Nojima M, Sonoda T, et al: Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer. Br J Cancer 98: 1147-1156, 2008.
23. Götze S, Wolter M, Reifenberger G, Müller O and Sievers S: Frequent promoter hypermethylation of Wnt pathway inhibitor genes in malignant astrocytic gliomas. Int J Cancer 126: 2584-2593, 2010.
24. Ding Z, Qian YB Zhu LX and Xiong QR: Promoter methylation and mRNA expression of Dkk-3 and WIF-1 in hepatocellular carcinoma. World J Gastroenterol 15: 2595-2601, 2009.
25. Fujikane T, Nishikawa N, Toyota M, Suzuki H, Nojima M, Maruyama R, Ashida M, Ohe-Toyota M, Kai M, Nishidate T, et al: Genomic screening for genes upregulated by demethylation revealed novel targets of epigenetic silencing in breast cancer. Breast Cancer Res Treat 122: 699-710, 2010.
26. Veeck J, Bektas N, Hartmann A, Kristiansen G, Heindrichs U, Knüchel R and Dahl E: Wnt signaling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours. Breast Cancer Res 10: R82, 2008.
27. Licchesi JD, Westra WH, Hooker CM, Machida EO, Baylin SB and Herman JG: Epigenetic alteration of Wnt pathway antagonists in progressive glandular neoplasia of the lung. Carcinogenesis 29: 895-904, 2008.
28. Hirata H, Hinoda Y, Nakajima K, Kikuno N, Yamamura S, Kawakami K, Suehiro Y, Tabatabai ZL, Ishii N and Dahiya R: Wnt antagonist gene polymorphisms and renal cancer. Cancer 115: 4488-4503, 2009.
29. Pei Y, Kano J, Iijima T, Morishita Y, Inadome Y and Noguchi M: Overexpression of Dickkopf 3 in hepatoblastomas and hepatocellular carcinomas. Virchows Arch 454: 639-646, 2009.
30. Zitt M, Untergasser G, Amberger A, Moser P, Stadlmann S, Zitt M, Müller HM, Mühlmann G, Perathoner A, Margreiter R, Gunsilius E and Ofner D: Dickkopf-3 as a new potential marker for neoangiogenesis in colorectal cancer: expression in cancer tissue and adjacent non-cancerous tissue. Dis Markers 24: 101-109, 2008.
31. Untergasser G, Steurer M, Zimmermann M, Hermann M, Kern J, Amberger A, Gastl G and Gunsilius E: The Dickkopf-homolog 3 is expressed in tumor endothelial cells and supports capillary formation. Int J Cancer 122: 1539-1547, 2008.
32. Folkman J, Bach M, Rowe JW, Davidoff F, Lambert P, Hirsch C, Goldberg A, Hiatt HH, Glass J and Henshaw E: Tumor angiogenesis - therapeutic implications. N Engl J Med 285: 1182-1186, 1971.
33. Bergers G and Benjamin LE: Tumorigenesis and the angiogenic switch. Nat Rev Cancer 3: 401-410, 2003.
34. Carmeliet P and Jain RK: Angiogenesis in cancer and other diseases. Nature 407: 249-257, 2000.